Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology
Go back to Galmed publishes Results from Aramchol Phase 3 Open Label part in Hepatology| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 3.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.93 | 52 Week High | $9.70 | |||
| Open | $3.93 | 52 Week Low | $2.78 | |||
| Day High | $3.93 | P/E | N/A | |||
| Day Low | $3.93 | EPS | $0.00 | |||
| Volume | 5,459 | |||||
